Turmeric is a popular dietary supplement for managing arthritis, digestive problems, and liver disease. However, some ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

Scientists found brain cells behind semaglutide’s weight-loss power—and they don’t cause the nasty side effects.

Altimmune nears a key MASH trial readout, with strong market potential and new liver and alcohol studies supporting growth.

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

"Social media will turn everyone into brain-dead zombies with a medieval-level understanding of the real world." ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Growing demand for natural weight loss solutions drives the weight management supplements market across health-conscious consumer segments.

A miracle drug just wiped out WeightWatchers International’s (WW) 60-year empire. Here’s how Ozempic disrupted the weight ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...